Metformin - For the dermatologist

被引:38
作者
Bubna, Aditya Kumar [1 ]
机构
[1] Sri Ramachandra Univ, Dept Dermatol, Madras, Tamil Nadu, India
关键词
Hyperandrogenism; hyperinsulinemia; hyperpigmentary disorders; metformin; skin cancer; POLYCYSTIC-OVARY-SYNDROME; SQUAMOUS-CELL CARCINOMA; GROWTH-FACTOR-I; INSULIN-RESISTANCE; ACANTHOSIS NIGRICANS; SIGNALING PATHWAY; ANDROGEN EXCESS; INHIBITION; THERAPY; GIRLS;
D O I
10.4103/0253-7613.174388
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Metformin though primarily an antidiabetic drug, has found to play an important role in a number of cutaneous disorders. Because of its role in improving hyperinsulinemia, it has proven beneficial in hormonal acne, hidradenitis suppurativa (HS) and acanthosis nigricans. Its antiandrogenic properties further serve as an add-on to the conventional management of hirsutism associated with polycystic ovarian syndrome. Very recently, systemic usage of metformin for psoriasis and cutaneous malignancies has shown promising results. Interestingly, metformin has also been topically used in hyperpigmentary disorders with pertinent levels of improvement and happens to be the most recent addition to the list of dermatologic indications. Though an oral hypoglycemic agent to begin with, metformin today has proven to be a boon for dermatologists.
引用
收藏
页码:4 / 10
页数:7
相关论文
共 46 条
[1]   Long-standing hidradenitis suppurativa treated effectively with metformin [J].
Arun, B. ;
Loffeld, A. .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2009, 34 (08) :920-921
[2]  
Atabek ME, 2008, J PEDIATR ENDOCR MET, V21, P339
[3]   Lichen planus associated with metformin therapy [J].
Azzam, H ;
Bergman, R ;
FriedmanBirnbaum, R .
DERMATOLOGY, 1997, 194 (04) :376-376
[4]  
Barbato Mariana Tremel, 2012, An. Bras. Dermatol., V87, P97
[5]   Metformin and liraglutide ameliorate high glucose-induced oxidative stress via inhibition of PKC-NAD(P)H oxidase pathway in human aortic endothelial cells [J].
Batchuluun, Battsetseg ;
Inoguchi, Toyoshi ;
Sonoda, Noriyuki ;
Sasaki, Shuji ;
Inoue, Tomoaki ;
Fujimura, Yoshinori ;
Miura, Daisuke ;
Takayanagi, Ryoichi .
ATHEROSCLEROSIS, 2014, 232 (01) :156-164
[6]   Metformin: A Potential Drug to Treat Hyperpigmentation Disorders [J].
Belisle, Elisabeth S. ;
Park, Hee-Young .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 (10) :2488-2491
[7]  
Bellot-Rojas Paula, 2006, J Drugs Dermatol, V5, P884
[8]  
Bermudez-Pirela Valmore J, 2007, Am J Ther, V14, P194, DOI 10.1097/01.pap.0000249909.54047.0e
[9]   Metformin Blocks Melanoma Invasion and Metastasis Development in AMPK/p53-Dependent Manner [J].
Cerezo, Michael ;
Tichet, Melanie ;
Abbe, Patricia ;
Ohanna, Mickael ;
Lehraiki, Abdelali ;
Rouaud, Florian ;
Allegra, Maryline ;
Giacchero, Damien ;
Bahadoran, Philippe ;
Bertolotto, Corine ;
Tartare-Deckert, Sophie ;
Ballotti, Robert ;
Rocchi, Stephane .
MOLECULAR CANCER THERAPEUTICS, 2013, 12 (08) :1605-1615
[10]   Metformin, an Antidiabetic Agent Reduces Growth of Cutaneous Squamous Cell Carcinoma by Targeting mTOR Signaling Pathway [J].
Chaudhary, Sandeep C. ;
Kurundkar, Deepali ;
Elmets, Craig A. ;
Kopelovich, Levy ;
Athar, Mohammad .
PHOTOCHEMISTRY AND PHOTOBIOLOGY, 2012, 88 (05) :1149-1156